Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trialSelim Corbacioglu, Giorgio Dini, Ingo Müller et al.|The Lancet|2012Cited by 376
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III StudyChristina Peters, Peter Bader, Jean‐Hugues Dalle et al.|Journal of Clinical Oncology|2020Cited by 333
Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR studyFranco Locatelli, Vanderson Rocha, Alessandro Crotta et al.|Blood|2013Cited by 99
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow TransplantationAlexander Claviez, Norbert Schmitz, Daan Dierickx et al.|Blood|2009Cited by 77
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)Simone Cesaro, Carlo Dufour, Marta Pillon et al.|Bone Marrow Transplantation|2020Cited by 47